Home > Products > CD19 & CD64
> Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scFv-CH1/CL)
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-044)
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD19 antibody variable domain is fused to CH1 and the other scFv from an anti-CD64 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scFv-CH1/CL) (BSCC-044). Click the button below to contact us or submit your feedback about this product.